Advertisement
CRVL vs LMAT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVL is a Hold and LMAT is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRVL’s FA Score shows that 1 FA rating(s) are green whileLMAT’s FA Score has 2 green FA rating(s).
- CRVL’s FA Score: 1 green, 4 red.
- LMAT’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRVL’s TA Score shows that 3 TA indicator(s) are bullish while LMAT’s TA Score has 4 bullish TA indicator(s).
- CRVL’s TA Score: 3 bullish, 5 bearish.
- LMAT’s TA Score: 4 bullish, 5 bearish.
Price Growth
CRVL (@Insurance Brokers/Services) experienced а -3.93% price change this week, while LMAT (@Pharmaceuticals: Other) price change was -1.10% for the same time period.
The average weekly price growth across all stocks in the @Insurance Brokers/Services industry was -0.51%. For the same industry, the average monthly price growth was -3.32%, and the average quarterly price growth was -28.32%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.46%. For the same industry, the average monthly price growth was -1.34%, and the average quarterly price growth was -14.46%.
Reported Earning Dates
LMAT is expected to report earnings on Jul 23, 2026.
Industries' Descriptions
@Insurance Brokers/Services (-0.51% weekly)Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.
@Pharmaceuticals: Other (-3.46% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| CRVL | LMAT | CRVL / LMAT | |
| Capitalization | 2.9B | 2.09B | 139% |
| EBITDA | 168M | 96.3M | 174% |
| Gain YTD | -12.487 | 15.842 | -79% |
| P/E Ratio | 27.67 | 34.38 | 81% |
| Revenue | 941M | 256M | 368% |
| Total Cash | 230M | N/A | - |
| Total Debt | 25.9M | 186M | 14% |
CRVL | LMAT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 89 | 85 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 83 | 31 | |
SMR RATING 1..100 | 32 | 53 | |
PRICE GROWTH RATING 1..100 | 62 | 61 | |
P/E GROWTH RATING 1..100 | 95 | 70 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LMAT's Valuation (17) in the Medical Specialties industry is significantly better than the same rating for CRVL (98) in the Insurance Brokers Or Services industry. This means that LMAT’s stock grew significantly faster than CRVL’s over the last 12 months.
LMAT's Profit vs Risk Rating (31) in the Medical Specialties industry is somewhat better than the same rating for CRVL (83) in the Insurance Brokers Or Services industry. This means that LMAT’s stock grew somewhat faster than CRVL’s over the last 12 months.
CRVL's SMR Rating (32) in the Insurance Brokers Or Services industry is in the same range as LMAT (53) in the Medical Specialties industry. This means that CRVL’s stock grew similarly to LMAT’s over the last 12 months.
LMAT's Price Growth Rating (61) in the Medical Specialties industry is in the same range as CRVL (62) in the Insurance Brokers Or Services industry. This means that LMAT’s stock grew similarly to CRVL’s over the last 12 months.
LMAT's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as CRVL (95) in the Insurance Brokers Or Services industry. This means that LMAT’s stock grew similarly to CRVL’s over the last 12 months.
| CRVL | LMAT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 65% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 59% | 2 days ago 54% |
| MACD ODDS (%) | 2 days ago 72% | N/A |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 57% |
| Advances ODDS (%) | 5 days ago 72% | 2 days ago 69% |
| Declines ODDS (%) | 3 days ago 56% | 9 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 72% | 2 days ago 59% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| INQQ | 12.11 | 0.15 | +1.28% |
| INQQ The India Internet ETF | |||
| NVYY | 13.73 | 0.11 | +0.82% |
| GraniteShares YieldBOOST NVDA ETF | |||
| ECAT | 15.65 | 0.03 | +0.19% |
| BlackRock ESG Capital Allocation Term Trust | |||
| FCPI | 54.89 | 0.08 | +0.15% |
| Fidelity Stocks for Inflation ETF | |||
| MYCL | 24.57 | N/A | N/A |
| State Street® My2032 Corporate Bond ETF | |||
CRVL and
Correlation & Price change
A.I.dvisor tells us that CRVL and SLQT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRVL and SLQT's prices will move in lockstep.
| Ticker / NAME | Correlation To CRVL | 1D Price Change % | ||
|---|---|---|---|---|
| CRVL | 100% | +3.40% | ||
| SLQT - CRVL | 30% Poorly correlated | +5.67% | ||
| AON - CRVL | 29% Poorly correlated | +2.10% | ||
| ERIE - CRVL | 28% Poorly correlated | +5.92% | ||
| AJG - CRVL | 26% Poorly correlated | +4.20% | ||
| MRSH - CRVL | 24% Poorly correlated | +2.50% | ||
More | ||||
LMAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To LMAT | 1D Price Change % | ||
|---|---|---|---|---|
| LMAT | 100% | +2.03% | ||
| ITGR - LMAT | 48% Loosely correlated | +1.98% | ||
| SYK - LMAT | 46% Loosely correlated | +2.11% | ||
| UFPT - LMAT | 44% Loosely correlated | +2.82% | ||
| AORT - LMAT | 40% Loosely correlated | +1.26% | ||
| RDNT - LMAT | 39% Loosely correlated | +1.78% | ||
More | ||||